[10B2-10B2];[10B11-10B11];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
10B2;10B11
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC288 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(1)BSC288 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}f02333 and P{XP}d05722 transposable element insertions sites are 10B2;10B11.